ChemImage Presents Latest Developments For Detection Of Colorectal Cancer

PITTSBURGH, Feb. 3, 2015 /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick J. Treado, PhD, will be discussing an innovative diagnostic procedure for the detection of cancer during the SPIE Photonics West Biophotonics and Biomedical Optics (BiOS) conference in San Francisco, California.

Photo - http://photos.prnewswire.com/prnh/20150202/172785

Dr. Treado's presentation is entitled "Detection of Colorectal Cancer in Blood Serum Using Raman Molecular Imaging" and will be given on the morning of Monday, February 9, 2015 as part of the Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XIII program at BiOS.  The talk will detail the results of a study performed by scientists at ChemImage, in collaboration with gastroenterology clinicians, on the development of in vitro diagnostic (IVD) Raman assays focused on colorectal cancer detection.

"We are pleased to have the opportunity to share our findings with the biomedical spectroscopy community at Photonics West," said Patrick J. Treado, Chief Technology Officer at ChemImage. "Our research shows that Raman molecular imaging is a candidate method for rapid and high throughput evaluation of human tissue, cells and human bodily fluids, including blood serum, for disease diagnosis."

BiOS is the world's largest biophotonics and biomedical optics conference featuring over 2,700 presentations on clinical, translational, and fundamental research and development in the field of biomedical optics. More than 5,000 attendees are expected this year.

For more information regarding ChemImage's Raman molecular imaging capabilities, contact Patrick Treado at treado@chemimage.com.

About ChemImage 

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

Media Contact:Tifanie Tiberio, ChemImage Corporation, 412-241-7335 ext. 269, tiberiot@chemimage.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE ChemImage Corporation